About this trial
Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Women who delivered by a cesarean section.
Age over 18.
Fluent in Hebrew or Arabic.
Signed informed consent form.
Disqualifiers
Lack of consent or inability to provide informed consent.
Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit.
Women with preoperative coagulation disorders.
Women whose clinical condition requires a post-cesarean ultrasound examination.
Trial design
Parallel
Treatments tested in this trial
Ultrasound
Diagnostic testThe purpose of the test is to diagnose and assess the amount of blood loss.
Standard care
Other interventionRoutine management
Treatment groups
Trial outcomes
Primary outcomes
Hemoglobin drop of 2g% or more within 24 - 36 hours
The proportion of women with a decrease in Hb levels of over 2 g% identified within 24 hours of surgery in both groups.
Secondary outcomes
HB levels after 48-72
Difference in average HB levels after 48-72 hours between the two study groups
Inferior Vena Cava (IVC) diameter
Measurement of IVC diameter during inspiration and expiration
IVC collapsibility index
IVC expiration-IVC inspiration/IVC expiration
Uterine walls diameter
Measured midway between the fundus and the cervix of the uterus
Sponsors and contacts
Click on the lead sponsor to view all of their trials.